Rosca, Paula, Alexander Grinshpoon, Keren Goldman, Anatoly Margolis, and Alexander M. Ponizovsky. “The Israeli National Substance Abuse Treatment Registry (INSATR): A Review of the Registry-based Research Findings and Future Implications.” Frontiers in Clinical Medicine 2.1 (2015): 20-27.
Substance-related disorders are a major public health problem, requiring the development of primary and secondary prevention programs. The Department for the Treatment of Substance Abuse in the Israeli Ministry of Health maintains an administrative database that includes information on all patients enrolled in substitution programs for substance-related disorders. The Israel National Substance Abuse Treatment Registry (INSATR) was introduced in 1996 to ascertain demographic and clinical characteristics of patients, treatment details and legal data that can contribute to the improvement of care coordination, improved population health outcomes and more robust research data for epidemiological, clinical and service policy research. The aim of this report is to describe the INSATR and illustrate its benefits through a review of the findings of INSATR-related clinical trials and linkage studies to other national registries: the National Psychiatric Hospitalization Registry, National Cancer Registry and National AIDS Registry. The INSATR has demonstrated meaningful use in the assessment of quality of care and quality assurance, and in public health service policies research directed to the development of secondary prevention programs for individuals with substance-related problems in the community.